search
Back to results

The Use of Barbed Sutures in Total Hip Arthroplasty

Primary Purpose

Osteoarthritis, Hip

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Interrupted Knotted Sutures
STRATAFIX Symmetric PDS PLUS Knotless Tissue Control Devices
Sponsored by
Rothman Institute Orthopaedics
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osteoarthritis, Hip

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion criteria:

  • All patients receiving elective primary THA through the direct anterior approach, treated by the primary investigator (JP) at the Thomas Jefferson University Hospital or Rothman Specialty Hospital.

Exclusion Criteria:

  • Prior surgical incision or scar in close proximity of the proposed incision (<2 cm).
  • Local skin conditions such as dermatitis, eczema, or psoriasis.
  • Active or previous infection in the skin or the hip.
  • Inflammatory arthritis; connective tissue or vascular disorders or diseases that would adversely affect wound healing including the use of oral or topical cortico-steroid use

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    Inturrupted Knotte Sutures

    Barbed Sutures

    Arm Description

    Outcomes

    Primary Outcome Measures

    Incidence of suture abscess or other wound related compilation

    Secondary Outcome Measures

    Full Information

    First Posted
    November 17, 2015
    Last Updated
    September 5, 2023
    Sponsor
    Rothman Institute Orthopaedics
    Collaborators
    Ethicon, Inc.
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02609464
    Brief Title
    The Use of Barbed Sutures in Total Hip Arthroplasty
    Official Title
    The Use of Barbed Sutures in Total Hip Arthroplasty: A Prospective, Randomized, and Controlled Clinical Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    September 2023
    Overall Recruitment Status
    Completed
    Study Start Date
    December 1, 2015 (Actual)
    Primary Completion Date
    March 1, 2020 (Actual)
    Study Completion Date
    March 1, 2020 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Rothman Institute Orthopaedics
    Collaborators
    Ethicon, Inc.

    4. Oversight

    5. Study Description

    Brief Summary
    The purpose of this study is to evaluate the role of new barbed suture for closure of wound during total hip arthroplasty in reducing the risk for wound healing problems.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Osteoarthritis, Hip

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Outcomes Assessor
    Allocation
    Randomized
    Enrollment
    100 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Inturrupted Knotte Sutures
    Arm Type
    Active Comparator
    Arm Title
    Barbed Sutures
    Arm Type
    Active Comparator
    Intervention Type
    Device
    Intervention Name(s)
    Interrupted Knotted Sutures
    Intervention Type
    Device
    Intervention Name(s)
    STRATAFIX Symmetric PDS PLUS Knotless Tissue Control Devices
    Primary Outcome Measure Information:
    Title
    Incidence of suture abscess or other wound related compilation
    Time Frame
    Within 30 days of surgery

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion criteria: All patients receiving elective primary THA through the direct anterior approach, treated by the primary investigator (JP) at the Thomas Jefferson University Hospital or Rothman Specialty Hospital. Exclusion Criteria: Prior surgical incision or scar in close proximity of the proposed incision (<2 cm). Local skin conditions such as dermatitis, eczema, or psoriasis. Active or previous infection in the skin or the hip. Inflammatory arthritis; connective tissue or vascular disorders or diseases that would adversely affect wound healing including the use of oral or topical cortico-steroid use

    12. IPD Sharing Statement

    Learn more about this trial

    The Use of Barbed Sutures in Total Hip Arthroplasty

    We'll reach out to this number within 24 hrs